This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Print Page  |  Contact Us  |  Report Abuse  |  Sign In  |  Register
Partners and Sponsors
Share |



The Lipoprotein(a) Foundation is a patient-founded, 501(c)3 non-profit organization dedicated to preventing cardiovascular events due to high Lipoprotein(a) by diagnosing the most prevalent genetic risk for cardiovascular disease; educating and empowering patients and saving lives.  We are fortunate to have such loyal and compassionate companies supporting our organization, and we thank them on behalf of the 1 in 5 people globally who have been affected by high Lipoprotein(a).

We do our utmost to develop strategic partnerships with companies who share our mission and values – saving lives by increasing awareness, advocating for routine testing, and supporting research that will lead to a specific treatment for high Lipoprotein(a). We invite you to make a difference by supporting our strategic objectives throughout the year. Sponsorship is a tremendous gift and demonstration of your commitment to the Lp(a) Community.  Please contact Thank you.


2019 Disease Awareness Partners






Thank you to the following companies for their current pro bono services:

WilsonLogoWilson Sonsini Goodrich & Rosati is the premier legal advisor to technology, life sciences, and other growth enterprises worldwide. We represent companies at every stage of development, from entrepreneurial start-ups to multibillion-dollar global corporations, as well as the venture firms, private equity firms, and investment banks that finance and advise them. The firm's broad range of services and practice areas are focused on addressing the principal challenges faced by the management, boards of directors, shareholders, and in-house counsel of our clients.




Carmone Design


Academic and Government Partners


The European Atherosclerosis Society (EAS) was founded in 1964 with the aim of “advancing and exchanging knowledge concerning the causes, natural history, treatment and prevention of atherosclerotic disease.” For more than 50 years the Society’s expertise has been used to teach clinicians how to manage lipid disorders and how to prevent atherosclerosis. By offering to our members access to educational materials, and opportunities to take part in Congress and courses, and by providing a forum in which new developments can be discussed, EAS contributes to the development of knowledge in the field, and ultimately to the improved treatment of persons with cardiovascular disease and lipid disorders.


Community Search
Sign In
Login with LinkedIn


The upcoming calendar is currently empty.

Click here to view past events and photos »

Latest News
809 Laurel Street #460
San Carlos, CA 94070